Table 3.

Relation between the levels of expression of H19 and MALAT1 with type-2 diabetes, metabolic syndrome, and biochemical measurements.

	Serum				Exosomes
	H19		MALAT1		H19		MALAT1
	β (95% CI)	p	β (95% CI)	p	β (95% CI)	p	β (95% CI)	p
T2D	−0.24 (−1.0, 0.56)	0.555	−0.62 (−0.96, −0.27)	< 0.001	−0.43 (−1.5, 0.68)	0.444	−0.70 (−1.25, −0.15)	0.013
MetS	−0.53 (−1.41, 0.35)	0.240	−0.33 (−0.71, 0.06)	0.099	−0.34 (−1.48, 0.81)	0.565	−0.64 (−1.19, −0.09)	0.023
WC, cm ≥ 102 male/88 female	−0.22 (−1.02, 0.58)	0.591	0.01 (−0.35, 0.38)	0.946	0.53 (−0.55, 1.62)	0.336	−0.50 (−1.07, 0.06)	0.080
BP, mmHg ≥135/85	−0.26 (−1.19, 0.67)	0.589	−0.21 (−0.66, 0.25)	0.374	0.80 (−0.48, 2.08)	0.223	−0.25 (−0.98, 0.47)	0.495
TG, mg/dL ≥ 150	−0.42 (−1.22, 0.37)	0.298	−0.03 (−0.40, 0.33)	0.855	−0.42 (−1.54, 0.70)	0.465	−0.07 (−0.66, 0.51)	0.804
HDL-c, mg/dL <40 male/50 female	0.34 (−0.46, 1.13)	0.406	−0.47 (−0.83, −0.12)	0.009	−0.49 (−1.62, 0.63)	0.389	−0.15 (−0.76, 0.44)	0.618
HbA1c ≥ 7%	1.07 (−0.05, 2.19)	0.060	−0.14 (−0.45, 0.16)	0.375	0.42 (−1.38, 2.23)	0.645	−0.03 (−0.80, 0.74)	0.945

Β, Regression coefficient calculated by generalized linear models adjusted for age; CI, Confidence interval; T2D, Type-2 diabetes; MetS, Metabolic syndrome; WC, Waist circumference; BP, Blood pressure; TG, Triglycerides; HDL-c, High-density lipoprotein cholesterol; HbA1c, Glycosylated hemoglobin.